Modeling risk stratification in human cancer.

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• Gene expression-based survival prediction holds prognostic promise but sees limited clinical use due to analysis complexities and restricted patient stratification.
• Existing methods often assess only a single high-risk group, leaving most patients unclassified and limiting clinical utility.
• Addressing these challenges is crucial for advancing personalized cancer care through genomic data.

Purpose of the Study:

• To develop a robust, mathematically defined, multi-group risk stratification model for cancer survival prediction.
• To validate the model's performance on independent cohorts, treating each patient as a new entry.
• To provide an open-access web tool for real-time risk assessment of individual patients.

Main Methods:

• Utilized gene expression profiles from 551 multiple myeloma, 602 breast-cancer, and 460 glioma patients.
• Employed running log-rank tests under controlled chi-square conditions with multiple testing corrections.
• Developed a risk score and classification algorithm through simultaneous global and between-group log-rank chi-square maximization.

Main Results:

• A statistically significant three-group risk prediction model was established for each cancer type.
• Model performance was corroborated using publicly available validation cohorts.
• The developed risk score demonstrates favorable comparison with prior risk classification methods.

Conclusions:

• The novel risk score, constrained by between-group significances, offers improved risk stratification.
• The developed methodology overcomes limitations of previous gene expression-based survival analyses.
• An accessible web tool is available for practical clinical application of the risk prediction model.